Hasegawa Suguru
Intensive Care Medicine, Toyama Prefectural Central Hospital, Toyama, JPN.
Cureus. 2025 Mar 15;17(3):e80620. doi: 10.7759/cureus.80620. eCollection 2025 Mar.
Streptococcal toxic shock syndrome (STSS) is a rapidly progressing and life-threatening illness caused by group A Streptococcus (GAS), typically associated with invasive infections such as necrotizing fasciitis and characterized by high mortality rates. Although GAS is an uncommon cause of community-acquired pneumonia (CAP), it can lead to severe illness in both healthy individuals and those with comorbidities. We report a case of STSS with pneumonia in a previously healthy 69-year-old female who presented with severe respiratory distress and shock without skin lesions. Despite the rapid progression typical of STSS, the patient showed remarkable clinical improvement with tazobactam/piperacillin and azithromycin, without the administration of clindamycin. This study challenges the conventional approach that emphasizes clindamycin due to its antitoxin effects, highlighting the importance of individualized therapeutic decisions. This case underscores the necessity of considering STSS in the differential diagnosis of severe respiratory infections in adults, even in the absence of skin manifestations. Further research is needed to clarify the role of antitoxin therapies and to establish evidence-based guidelines for managing STSS, particularly in cases presenting with pneumonia without skin involvement.
链球菌中毒性休克综合征(STSS)是一种由A组链球菌(GAS)引起的进展迅速且危及生命的疾病,通常与坏死性筋膜炎等侵袭性感染相关,死亡率很高。虽然GAS是社区获得性肺炎(CAP)的罕见病因,但它可导致健康个体和合并症患者出现严重疾病。我们报告一例STSS合并肺炎的病例,患者为一名69岁既往健康女性,表现为严重呼吸窘迫和休克,无皮肤病变。尽管STSS具有典型的快速进展特点,但该患者使用他唑巴坦/哌拉西林和阿奇霉素后临床症状显著改善,未使用克林霉素。本研究对因克林霉素具有抗毒素作用而强调使用它的传统方法提出了挑战,凸显了个体化治疗决策的重要性。该病例强调了在成人严重呼吸道感染的鉴别诊断中考虑STSS的必要性,即使没有皮肤表现。需要进一步研究以阐明抗毒素疗法的作用,并建立基于证据的STSS管理指南,特别是对于无皮肤受累的肺炎病例。